Germany announced on March 30 that it would no longer offer the two-dose AstraZeneca vaccine to people aged under 60 due to concerns over a possible link to rare cases of blood clots.
DPA news agency said ministers agreed at a meeting that people in the younger age group who received a first AstraZeneca dose before the March 30 announcement will be offered either the BioNTech-Pfizer jab for their second dose, or the Moderna vaccine.
No comments:
Post a Comment
Only News